Insider Transactions Reported by 18 Insiders of RIGEL PHARMACEUTICALS INC

Symbol
RIGL on Nasdaq
Location
South San Francisco, CA

Insiders trading volume in the past year

RIGEL PHARMACEUTICALS INC executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
RAUL R. RODRIGUEZ CEO, President, Director $10,569,997 17 Feb 2026
Dean L. Schorno EVP & Chief Financial Officer $2,861,110 17 Feb 2026
David A. Santos EVP, Chief Commercial Officer $2,356,367 17 Feb 2026
Raymond Furey EVP, GC, CCO & Corp Sec $1,941,951 17 Feb 2026
Lisa Rojkjaer EVP, Chief Medical Officer $1,306,290 17 Feb 2026
WALTER H. MOOS Director $462,571 -$145,440 -24% 20 Feb 2026
Gregg A. Lapointe Director $238,250 23 May 2025
Jane Wasman Director $238,250 23 May 2025
ALISON L. HANNAH Director $202,512 23 May 2025
Kamil Ali-Jackson Director $178,687 23 May 2025
GARY A. LYONS Director $131,250 26 May 2023
Wolfgang Dummer Evp & Cmo $126,803 02 Feb 2023
Brian L. Kotzin Director $114,000 25 May 2024
Bradford S. Goodwin Director $61,250 19 May 2021
Keith Katkin Director $43,750 19 May 2021
Mark W. Frohlich Director $23,825 23 May 2025
MICHAEL PATRICK MILLER Director $8,009 01 Feb 2026
Dolly Vance EVP Corp. Affairs, G.C., Sect. 14 Sep 2022

Recent Insider Transactions by Companies or Individuals for RIGEL PHARMACEUTICALS INC

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.